Clustering data with hclust algorithm for Metabolic effects of weight reduction of very low energy diet vs dietary counseling (Study ST000708)

C18 NEGATIVE ION MODE (Analysis AN001101)
MetaboliteStructureF1F2F3F4F5
FFA(24:3)ME199590NA1.871.030.630.63
PE 30:0; [M-H]-@6.07ME199620NA1.490.891.290.38
PC 32:3; [M-Ac-H]-@5.15ME199596NA1.360.711.390.50
CL 66:1; [M-2H](2-)@6.23ME199570NA1.210.631.460.61
PE 32:1; [M-H]-@6.22ME199621NA1.150.611.480.66
PS 38:4; [M-H]-@5.98ME199654NA0.951.800.590.92
PS 36:1; [M-H]-@6.40ME199653NA1.061.440.700.96
CL 78:1; [M-2H](2-)@7.90ME199573NA0.861.460.960.85
PE 38:1; [M-H]-@7.92ME199630NA0.861.590.920.80
PC 37:3; [M-Ac-H]-@6.71ME199611NA0.760.871.191.10
PE 35:2; [M-H]-@6.68ME199624NA0.750.721.341.07
CL 76:3; [M-2H](2-)@7.08ME199572NA1.140.650.961.15
lysoPE 20:3; [M-H]-@1.64ME199656NA1.080.641.051.12
lysoPE 22:6; [M-H]-@1.29ME199657NA0.960.641.041.23
PE 35:4; [M-H]-@6.04ME199625NA0.980.621.161.10
PG 36:3; [M-H]-@5.28ME199639NA0.930.990.861.20
FFA(20:1)ME199581NA0.890.830.981.23
FFA(20:2)ME199582NA0.920.820.981.21
Arachidonic acidME199569NA0.860.870.941.27
PC 35:1; [M-Ac-H]-@7.03ME199602NA0.860.900.971.21
FFA(18:1)ME199578NA0.950.781.011.18
FFA(18:2)ME199579NA0.980.741.051.14
FFA(22:3)ME199586NA1.000.840.991.12
PC 37:6; [M-Ac-H]-@5.80ME199612NA0.950.900.991.12
lysoPE 18:2; [M-H]-@1.36ME199655NA1.170.681.170.90
plasmenyl-PE 34:2; [M-H]-@6.71ME199659NA1.180.791.210.78
PC 32:2; [M-Ac-H]-@5.62ME199595NA1.001.051.280.68
PC 30:0; [M-Ac-H]-@5.96ME199591NA1.170.981.200.66
plasmenyl-PE 36:2; [M-H]-@7.31ME199661NA1.140.921.160.77
PC 33:0; [M-Ac-H]-@6.81ME199597NA0.920.921.290.83
PC 36:5; [M-Ac-H]-@5.71ME199608NA0.970.851.150.98
PC 36:6; [M-Ac-H]-@5.46ME199609NA1.000.881.100.98
CerP 34:1; [M-H]-@5.83ME199575NA0.910.911.190.95
PC 34:3; [M-Ac-H]-@5.80ME199601NA0.970.891.180.92
PE 33:2; [M-H]-@6.07ME199622NA0.980.871.230.88
CL 82:15; [M-2H](2-)@5.89ME199574NA0.921.001.150.92
PC 34:2; [M-Ac-H]-@6.21ME199600NA1.010.961.100.92
PC 38:2; [M-Ac-H]-@7.45ME199613NA1.031.011.110.86
PC 38:3; [M-Ac-H]-@7.08ME199614NA1.011.021.090.89
PC 33:2; [M-Ac-H]-@5.96ME199599NA0.941.021.040.99
PI 38:5; [M-H]-@5.35ME199650NA0.951.011.070.96
PI 38:3; [M-H]-@6.07ME199648NA0.931.111.000.98
PE 38:2; [M-H]-@6.88ME199631NA0.941.091.040.95
PI 36:2; [M-H]-@5.89ME199644NA0.941.081.050.95
PE 36:0; [M-H]-@7.84ME199626NA0.971.201.010.89
PE 40:4; [M-H]-@7.42ME199632NA0.991.180.990.91
plasmenyl-PE 42:5; [M-H]-@7.86ME199672NA1.001.091.010.93
PC 36:1; [M-Ac-H]-@7.30ME199606NA1.051.120.990.89
PC 40:4; [M-Ac-H]-@7.32ME199616NA1.041.081.040.88
PC 35:3; [M-Ac-H]-@6.08ME199604NA0.920.941.101.00
PC 36:4; [M-Ac-H]-@6.06ME199607NA0.900.961.071.04
PE 40:7; [M-H]-@6.39ME199633NA0.890.961.071.06
FFA(22:1)ME199584NA1.050.900.971.06
PC 38:5; [M-Ac-H]-@6.38ME199615NA0.980.981.001.03
FFA(22:2)ME199585NA1.050.941.001.00
FFA(16:0)ME199576NA1.030.941.001.02
FFA(22:0)ME199583NA1.010.950.991.03
FFA(18:0)ME199577NA0.991.010.961.04
FFA(20:0)ME199580NA1.011.020.941.04
FFA(24:2)ME199589NA0.961.030.951.07
PC 32:0; [M-Ac-H]-@6.61ME199593NA0.971.060.931.06
FFA(24:1)ME199588NA0.990.990.901.12
PC 40:6; [M-Ac-H]-@6.72ME199618NA0.940.990.951.10
PI 37:4; [M-H]-@5.57ME199647NA0.961.220.900.99
plasmenyl-PE 40:6; [M-H]-@7.19ME199670NA0.971.160.921.00
PI 40:5; [M-H]-@5.96ME199651NA0.841.250.911.05
PC 33:1; [M-Ac-H]-@6.43ME199598NA0.941.300.850.99
PI 38:4; [M-H]-@5.87ME199649NA0.911.300.871.00
PC 35:2; [M-Ac-H]-@6.56ME199603NA0.701.061.121.09
PE 37:6; [M-H]-@5.90ME199629NA0.731.091.200.97
PI 40:6; [M-H]-@5.79ME199652NA0.741.190.911.18
PG 33:0; [M-H]-@6.05ME199636NA0.761.281.001.02
PC 35:4; [M-Ac-H]-@5.93ME199605NA0.801.071.001.12
PC 40:7; [M-Ac-H]-@6.23ME199619NA0.841.101.011.06
PC 37:2; [M-Ac-H]-@7.22ME199610NA0.811.121.071.01
PE 37:4; [M-H]-@6.66ME199628NA0.741.181.041.05
PG 36:0; [M-H]-@6.87ME199637NA0.791.160.991.08
PI 36:1; [M-H]-@6.31ME199643NA1.401.090.900.70
PE 36:5; [M-H]-@6.00ME199627NA1.350.801.110.73
CL 74:1; [M-2H](2-)@6.79ME199571NA1.260.951.080.74
plasmenyl-PE 38:1; [M-H]-@8.23ME199664NA1.360.940.990.75
PC 30:1; [M-Ac-H]-@5.41ME199592NA1.231.221.070.60
PI 34:2; [M-H]-@5.24ME199642NA0.971.221.100.78
plasmenyl-PE 40:4; [M-H]-@7.75ME199668NA1.161.180.870.87
PI 36:4; [M-H]-@5.22ME199646NA1.071.210.890.91
plasmenyl-PE 42:4; [M-H]-@8.21ME199671NA1.111.210.840.92
plasmenyl-PE 42:6; [M-H]-@7.75ME199673NA1.111.300.810.90
PE 42:9; [M-H]-@6.04ME199635NA1.161.320.840.81
PG 38:4; [M-H]-@6.06ME199640NA1.181.250.870.82
PE 35:1; [M-H]-@7.10ME199623NA1.140.921.060.87
PC 40:5; [M-Ac-H]-@7.01ME199617NA1.111.000.990.92
PE 40:8; [M-H]-@5.95ME199634NA1.141.020.970.91
plasmenyl-PE 38:4; [M-H]-@7.21ME199667NA1.091.140.940.89
PI 36:3; [M-H]-@5.46ME199645NA1.141.080.910.92
plasmenyl-PE 40:5; [M-H]-@7.35ME199669NA1.141.080.880.95
PI 34:1; [M-H]-@5.68ME199641NA1.101.171.000.80
PG 36:2; [M-H]-@6.07ME199638NA1.171.181.000.73
plasmenyl-PE 36:5; [M-H]-@6.30ME199663NA1.181.120.980.79
plasmenyl-PE 38:2; [M-H]-@7.87ME199665NA1.261.030.930.83
plasmenyl-PE 36:3; [M-H]-@6.87ME199662NA1.241.030.990.79
plasmenyl-PE 38:3; [M-H]-@7.55ME199666NA1.201.021.000.82
PC 32:1; [M-Ac-H]-@6.06ME199594NA1.151.061.110.72
plasmenyl-PE 34:1; [M-H]-@7.17ME199658NA1.181.021.050.78
FFA(24:0)ME199587NA1.141.041.050.81
plasmenyl-PE 36:1; [M-H]-@7.72ME199660NA1.111.081.050.80

Factors:

F1GROUP:POOLED | VISIT:POOLED
F2GROUP:Standard | VISIT:visit 1
F3GROUP:Standard | VISIT:visit 2
F4GROUP:VLED | VISIT:visit 1
F5GROUP:VLED | VISIT:visit 2
Data matrix
  logo